19.10.2012 • News

AMRI, Shire Extend API Supply Agreement

AMRI announced today that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing, whose parent company, Shire, is a global company that focuses its business on behavioral health, gastro intestinal diseases, rare diseases and regenerative medicine.

The agreement extends a previously existing agreement between the two companies.

The terms of the agreement are confidential.

 

Company

Logo:

Curia


Albany, NY
US

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.